BRIEF published on 10/01/2024 at 00:45, 1 year 8 months ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 et ses mises à jour stratégiques Résultats Financiers Plateforme PlatONTM Acquisition D'Emglev Essai Clinique VIO-01 Innovations Thérapeutiques
BRIEF published on 10/01/2024 at 00:45, 1 year 8 months ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 1 year 8 months ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 8 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 8 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 08/05/2024 at 19:23, 1 year 10 months ago Bilan semestriel du contrat de liquidité avec Kepler Cheuvreux Contrat De Liquidité Transactions Kepler Cheuvreux AMF Valerio Therapeutics
BRIEF published on 08/05/2024 at 19:23, 1 year 10 months ago Half-yearly review of the liquidity contract with Kepler Cheuvreux Liquidity Contract Transactions Kepler Cheuvreux AMF Valerio Therapeutics
PRESS RELEASE published on 08/05/2024 at 19:18, 1 year 10 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Valerio Therapeutics releases half-year liquidity contract statement revealing shares and trading volumes Liquidity Contract Shares AMF Decision Valerio Therapeutics Trading Volumes
PRESS RELEASE published on 08/05/2024 at 19:18, 1 year 10 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Bilan semestriel du contrat de liquidité entre Valerio Therapeutics et Kepler Cheuvreux. Détails des moyens et transactions au 30 juin 2024 Contrat De Liquidité Bilan Semestriel Transactions Kepler Cheuvreux Valerio Therapeutics
BRIEF published on 06/05/2024 at 07:05, 2 years ago Minutes of the general meeting of Valerio Therapeutics Biotechnology Voting Results General Meeting Resolutions Valerio Therapeutics
Published on 06/27/2026 at 16:50, 1 day 1 hour ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 16 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 17 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 18 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 19 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/28/2026 at 17:26, 25 minutes ago EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/27/2026 at 00:05, 1 day 17 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 17 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
